Rheonix gets FDA nod for STI test, workstation

2019 05 02 23 38 2538 Check Mark 400

Rheonix announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its automated workstation software and molecular test for sexually transmitted infections (STIs).

The Encompass MDx workstation enables scalable, multiplexed sample-to-answer detection, simplifying laboratory workflows.

The Rheonix STI triplex assay and male urine collection kit is approved for simultaneous detection and differentiation of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.

Page 1 of 1